Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Surg Res ; 102(2): 144-9, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11796011

RESUMO

BACKGROUND: The mechanisms underlying the frequent development of carcinomas associated with ulcerative colitis (UC) are not understood. Cellular antioxidants play a crucial role in protection against neoplastic disease. The purpose of this study is to investigate a critical balance between free radical activity and the antioxidant defense system in carcinogenesis associated with UC, using a model of experimental colitis induced in mice by dextran sulfate sodium (DSS) treatment. METHODS: Chronic colitis was induced by feeding the mice for 7 days with 4% DSS, followed by drinking water alone for the subsequent 14 days. Animals were sacrificed after one, two, three, or four cycles of DSS administration. Development of dysplastic epithelium and invasive carcinoma was histologically examined. Lipid peroxide level was estimated by measuring malondialdehyde (MDA) content. Alterations in MDA content and superoxide dismutase (SOD) activity in colonic tissues together with production of serum tumor necrosis factor (TNF)-alpha were determined. RESULTS: Colonic neoplasms including dysplastic epithelium and invasive carcinoma developed in 28.6 and 25.0% of the animals at the end of the third and fourth cycles, respectively. In accordance with elevation of serum TNF-alpha level, there was a substantial increase in MDA in the colonic mucosa, while tissue SOD activity tended to be suppressed during the DSS treatment periods. Dysplastic epithelium and invasive carcinoma revealed significantly lower SOD levels compared with colonic colitis, although MDA levels were not statistically different among these colonic diseases. CONCLUSIONS: The results obtained in this experimental model suggest that an impaired antioxidant defense system might be critical for cancer development associated with UC.


Assuntos
Antioxidantes/metabolismo , Colite/metabolismo , Neoplasias do Colo/metabolismo , Animais , Anticoagulantes , Antioxidantes/farmacologia , Ácido Ascórbico/metabolismo , Ácido Ascórbico/farmacologia , Doença Crônica , Colite/induzido quimicamente , Colite/complicações , Neoplasias do Colo/etiologia , Neoplasias do Colo/prevenção & controle , Sulfato de Dextrana , Feminino , Radicais Livres/metabolismo , Mucosa Intestinal/enzimologia , Peróxidos Lipídicos/metabolismo , Malondialdeído/análise , Camundongos , Camundongos Endogâmicos , Superóxido Dismutase/análise , Superóxido Dismutase/farmacologia , Fator de Necrose Tumoral alfa/metabolismo
2.
Surgery ; 131(1 Suppl): S92-7, 2002 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11821793

RESUMO

BACKGROUND: Although intestinal permeability is known to increase in conditions of stress (such as endotoxemia, septic shock, and ischemia-reperfusion), the mechanism of gut barrier dysfunction during chemotherapy remains to be elucidated. We designed an experiment in which a gastrectomy and anticancer drugs were administered to rats to assess the extent of damage or an increase in permeability of the intestinal mucosa. METHODS: The rats were separated into the following groups: group A, no operation without an anticancer drug (control rats); group B, a gastric operation; group C, chemotherapy; and group D, a gastric operation followed by chemotherapy. Six rats were placed in each group. The groups that were given the anticancer drug received 45 mg/kg for 7 and 14 days, respectively. Intestinal permeability was determined by an injection of fluorescein isothiocyanate-dextran (FITC-D) intravenously and the measurement of the amount of FITC-D leakage in the luminal lavage. The plasma nitric oxide concentrations were measured spectrophotometrically by the Griess reaction. The cell surface expression of CD44 in the rat small intestine was evaluated immunohistochemically. RESULTS: During the entire experimental period, the FITC-D levels in the anticancer drug that was administrated to rats (groups C and D) were significantly higher than the levels in groups A and B (P <.001). Similarly, the plasma nitric oxide concentration increased significantly not only in groups C and D but also in group B (P <.05). A linear regression analysis revealed a positive significant correlation between FITC-D and the plasma nitric oxide levels (r = 0.617; P <.001). When the anticancer drug was administered, the intestine histologically revealed so-called mucosal atrophy and a decreased expression of CD44 within the intestinal mucosa. CONCLUSIONS: The administration of anticancer drugs impairs the gut barrier function, possibly by reducing the cell-cell and cell-matrix interactions. This may contribute to the development of hyperpermeability that is induced by an overexpression of nitric oxide.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia , Fluoresceína-5-Isotiocianato/análogos & derivados , Gastrectomia , Absorção Intestinal/efeitos dos fármacos , Óxido Nítrico/sangue , Tegafur/farmacologia , Uracila/farmacologia , Administração Oral , Animais , Dextranos/farmacocinética , Fluoresceína-5-Isotiocianato/farmacocinética , Mucosa Intestinal/lesões , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patologia , Masculino , Ratos , Ratos Sprague-Dawley , Estresse Fisiológico/metabolismo , Estresse Fisiológico/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...